-
Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
-
The clinical role of therapeutic drug monitoring of antiretrovirals : a Cochrane systematic review
-
Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
-
Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
-
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
-
Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
-
Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma
-
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
-
Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children
-
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
-
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
-
A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
-
Optimising methodology for the elicitation of participant-reported data relating to drug safety in resource poor settings
-
Prizidilol : analytical methods and in vitro metabolism by hepatic enzymes
-
A school-based intervention for improving malaria-related knowledge and practices in Maputo Province, Mozambique : a randomised controlled trial
-
Morbidity from antiretroviral metabolic effects in Africa: The Mama Study
-
Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa
-
The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
-
Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
-
Comparison of three levels of ascertainment of antenatal medication use at Gugulethu Midwife Obstetric Unit
-
Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
-
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
-
Screening rare filamentous actinobacteria for novel antimycobacterial compounds
-
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
